Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.